How Hims & Hers Health Is Quietly Changing Healthcare (NYSE:HIMS) Hims & Hers Health recurring revenue grew 111% YoY, boosted by personalization and chronic care. Forecasting $2.35B revenue by 2025.…
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. NEW YORK and NEW ORLEANS, July 18, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former…
Hims & Hers health CEO Dudum sells $2.5m in shares By Investing.com Hims & Hers health CEO Dudum sells $2.5m in shares…
Hims & Hers Health, Inc. (HIMS) Alleged "Deceptive" Marketing of Wegovy(R) Triggers Securities Class Actions Investors with Losses Encouraged to Contact Hagens Berman San Francisco, California--(Newsfile Corp. - July 18, 2025) - On June 25, 2025, securities class action lawsuits were filed against…
All You Need to Know About Hims & Hers Health (HIMS) Rating Upgrade to Strong Buy Hims & Hers Health (HIMS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the…
HIMS ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Hims & Hers Health, Inc. - August 25, 2025 Deadline Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
Weight-loss drugs telehealth platform Hims & Hers hit with new lawsuit Shareholder sues Hims & Hers board over failed weight-loss drug partnership deal.…
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the…
Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Hims & Hers Health, Inc.(HIMS) /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or…
Hims & Hers Aktie: Digital-Health-Überflieger oder nur selektives Interesse? Truist hebt Kursziel an! Charlotte, NC (www.aktiencheck.de) - Hims & Hers-Aktienanalyse von Truist: Die Analysten von Truist erhöhen das Kursziel für die Aktie von Hims…
HIMS SECURITIES FRAUD: Hims & Hers Health, Inc. (NYSE:HIMS) 34% Stock Drop Triggers Class Action Lawsuit – Contact BFA Law by August 25 Legal Deadline Hims & Hers Health, Inc. investors that lost money are notified to contact BFA Law before the August 25, 2025…